Evidence map›Paper›PMID 31901198›Full record

ArticleMedical science monitor : international medical journal of experimental and clinical research2020

Protective Effects of Naringin in Cerebral Infarction and Its Molecular Mechanism.

Jinping Yang, Lei Yuan, Ying Wen, Haiyan Zhou, Wenhan Jiang, Dan Xu, Minling Wang

Open access · hybridAbstract read
In one paragraph

Article in Medical science monitor : international medical journal of experimental and clinical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Naringenin Nanoformulations for Neurodegenerative Diseases.Current pharmaceutical biotechnology · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Network pharmacology andPharmaceutical biology · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jinping YangDepartment of Encephalopathy, Taicang City Hospital of Traditional Chinese Medicine, Taicang, Jiangsu, China (mainland).
Lei YuanDepartment of Encephalopathy, Taicang City Hospital of Traditional Chinese Medicine, Taicang, Jiangsu, China (mainland).
Ying WenDepartment of Encephalopathy, Taicang City Hospital of Traditional Chinese Medicine, Taicang, Jiangsu, China (mainland).
Haiyan ZhouDepartment of Encephalopathy, Taicang City Hospital of Traditional Chinese Medicine, Taicang, Jiangsu, China (mainland).
Wenhan JiangDepartment of Encephalopathy, Taicang City Hospital of Traditional Chinese Medicine, Taicang, Jiangsu, China (mainland).
Dan XuDepartment of Encephalopathy, Taicang City Hospital of Traditional Chinese Medicine, Taicang, Jiangsu, China (mainland).
Minling WangDepartment of Encephalopathy, Taicang City Hospital of Traditional Chinese Medicine, Taicang, Jiangsu, China (mainland).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Cerebral infarction is a cardiovascular disease with high morbidity and mortality. At present, many studies have reported the treatment of cerebral infarction by traditional Chinese medicine. Naringin, a flavonoid, is a major traditional Chinese medicine. However, the effect and mechanism of naringin on cerebral infarction is unclear. MATERIAL AND METHODS In our study, we established a rat model of cerebral infarction through middle cerebral artery occlusion (MCAO) to study the influence of naringin on cerebral infarction in vivo. After treatment with naringin, brain water content was detected to assess brain edema. Cerebral infarction volume and neurological deficits were also measured. Production of the inflammatory factors tumor necrosis factor (TNF)-alpha and interleukin (IL)-6) was measured using enzyme-linked immunosorbent assay (ELISA). Besides, the effect of naringin on cerebral infarction was investigated in vitro by establishing an oxygen-glucose deprivation (OGD) model in neuronal cells. Cell apoptosis and cell viability was determined using flow cytometry and MTT assay. RESULTS We found that naringin pretreatment significantly decreased the brain water content, cerebral infarction volume, and neurological deficit scores of MCAO subjected rats. And naringin treatment reduced apoptosis of nerve cells in rat hippocampus and the secretion of inflammatory factor such as TNF-alpha and IL-6. Besides, we found that naringin increased cell viability and inhibited apoptosis in OGD induced neuronal cells. Finally, we found that naringin promoted the expression of p-AKT protein in a concentration-dependent manner and activated the PI3K/AKT pathway in OGD induced neurons. CONCLUSIONS Naringin played a protective role in cerebral infarction via suppressing neuronal apoptosis and inflammation.

Indexed as

AnimalsApoptosisBrainBrain IschemiaCell SurvivalCerebral InfarctionDisease Models, AnimalFlavanonesHippocampusInfarction, Middle Cerebral ArteryInflammationInterleukin-6MaleMedicine, Chinese TraditionalNeuronsNeuroprotective AgentsFlavanonesInterleukin-6naringinNeuroprotective AgentsPhosphatidylinositol 3-KinasesTumor Necrosis Factor-alpha

Identifiers

PMID31901198
PMCPMC6977645
OpenAlexW3000714722

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.